We investigated the efficacy of Shakuyaku-kanzo-to (TJ-68) in neuroleptic-induced hyperprolactinemia in 11 treated schizophrenic patients. The mean plasma prolactin level decreased significantly from 28.9 ± 14.5 ng/mL at baseline to 22.0 ± 15.2 ng/mL at 4 weeks. Potassium levels did not change significantly. Neither the exacerbation of psychosis nor other adverse effects occurred.
|Number of pages||2|
|Journal||Psychiatry and clinical neurosciences|
|Publication status||Published - Jan 1 1996|
All Science Journal Classification (ASJC) codes
- Clinical Neurology
- Psychiatry and Mental health